Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naohiro Wada

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Hepatobiliary Surgery and Nutrition|December 12, 2025
Assessing the risk of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: is the Fibrosis-4 index still a reliable tool?Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 16, 2014
Secondary pseudohypoaldosteronism causing cardiopulmonary arrest and cholelithiasisTetsuya Kibe, Takehiro Sobajima, Ayumi Yoshimura, et al.
Pediatric Nephrology (Berlin, Germany)|October 18, 2006
Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndromeShori Takahashi, Naohiro Wada, Hitohiko Murakami, et al.
Hepatobiliary Surgery and Nutrition|October 27, 2023
Tropifexor, a selective non-acid farnesoid X receptor agonist, improved nonalcoholic steatohepatitis in a phase 2 trial, but several issues remain to be resolvedMasato Yoneda, Takashi Kobayashi, Naohiro Wada, et al.
Expert Opinion on Emerging Drugs|March 12, 2024
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitisMichihiro Iwaki, Masato Yoneda, Naohiro Wada, et al.
Pediatric Research|January 28, 2006
Charge selective function in childhood glomerular diseasesShori Takahashi, Saori Watanabe, Naohiro Wada, et al.
Nihon Jinzo Gakkai Shi|November 22, 2005
[Treatment guidelines for the idiopathic nephrotic syndrome in children]Norishige Yoshikawa, Masataka Honda, Kouji Sekine, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
Kidney transplantation in pediatric recipients with mental retardation: clinical results of a multicenter experience in JapanToshiyuki Ohta, Osamu Motoyama, Kota Takahashi, et al.
Clinical Journal of Gastroenterology|April 19, 2023
Mortality associated with the development of acute liver failure after a single dose of nivolumabAsako Nogami, Naohiro Wada, Erika Muraoka, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 2014
Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort studyKenji Ishikura, Osamu Uemura, Yuko Hamasaki, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Hepatobiliary Surgery and Nutrition|December 12, 2025
Assessing the risk of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: is the Fibrosis-4 index still a reliable tool?Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 16, 2014
Secondary pseudohypoaldosteronism causing cardiopulmonary arrest and cholelithiasisTetsuya Kibe, Takehiro Sobajima, Ayumi Yoshimura, et al.
Pediatric Nephrology (Berlin, Germany)|October 18, 2006
Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndromeShori Takahashi, Naohiro Wada, Hitohiko Murakami, et al.
Hepatobiliary Surgery and Nutrition|October 27, 2023
Tropifexor, a selective non-acid farnesoid X receptor agonist, improved nonalcoholic steatohepatitis in a phase 2 trial, but several issues remain to be resolvedMasato Yoneda, Takashi Kobayashi, Naohiro Wada, et al.
Expert Opinion on Emerging Drugs|March 12, 2024
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitisMichihiro Iwaki, Masato Yoneda, Naohiro Wada, et al.
Pediatric Research|January 28, 2006
Charge selective function in childhood glomerular diseasesShori Takahashi, Saori Watanabe, Naohiro Wada, et al.
Nihon Jinzo Gakkai Shi|November 22, 2005
[Treatment guidelines for the idiopathic nephrotic syndrome in children]Norishige Yoshikawa, Masataka Honda, Kouji Sekine, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
Kidney transplantation in pediatric recipients with mental retardation: clinical results of a multicenter experience in JapanToshiyuki Ohta, Osamu Motoyama, Kota Takahashi, et al.
Clinical Journal of Gastroenterology|April 19, 2023
Mortality associated with the development of acute liver failure after a single dose of nivolumabAsako Nogami, Naohiro Wada, Erika Muraoka, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 2014
Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort studyKenji Ishikura, Osamu Uemura, Yuko Hamasaki, et al.
Pageof 4